In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | N/A | |
2022 | N/A | |
2021 | N/A | -100% |
2020 | $0.25 M | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | -100% |
2016 | $0.08 M | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A | |
2012 | N/A | |
2011 | N/A | -100% |
2010 | $0.48 M | -45.67% |
2009 | $0.9 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.79 B | N/A | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | N/A | ๐บ๐ธ USA |